Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Haut und Haare: Die dermatologische Perspektive
Yaar M, Gilchrest BA. Aging and photoaging of keratinocytes and melanocytes. Clin Exp Dermatol 2001; 26: 583–591
Kligman AM, Balin AK. Aging of human skin. In: Balin AK, Kligman AM (Hrsg.). Aging and the skin. New York Raven Press 1989: 1–42
Fisher GJ, Kang S, Varani J et al. Mechanisms of photoaging and chronological sin aging. Arch Dermatol 2002; 138: 1462–1470
Yaar M. Mechanisms of aging (editorial) Arch Dermatol 2002; 138: 1429–1432
Li GZ, Eller MS, Firozabadi R, Gilchrest BA. Evidence that exposure of the telomere 3′ overhang sequence induces senescence. Proc Natl Acad Sci USA 2003; 100: 527–531
Hensley K, Floyd R. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 2002; 397: 377–383
Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection (CME article) J Am Acad Dermatol 2003; 48: 1–19
Passi S, De Pittá O, Puddu P, Littarru GP. Lipophilic antioxidants in human sebum and aging. Free Radical Research 2002; 36: 471–477
Thiele J. Hautalterung, ein multifaktorielles Phänomen — Antioxidanzien. Akt Dermatol 2002; 28: S3–S6
Scharfetter-Kochanek K. Chronological and photoaging of the dermal fibroblast and the connective tissue of the skin. Clin Exp Dermatol 2001; 26: 592–599
Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin aging. Clin Exp Dermatol 2001; 26: 573–577
Frances C. Smoking and the skin. Int J Dermatol 31: 779–780 (1992)
Haustein UF, Anderegg U. Vorzeitige Hautalterung durch Tabakrauchen. Hautarzt 2000; 51: 807–808
Trüeb RM. Association between smoking and hair loss: another opportunity for health education against smoking? Dermatology 2003; 206: 189–191
Commo S, Gaillard O, Bernard BA. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br J Dermatol 2004; 150: 435–443
Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol 2001; 36: 29–54
Nagl W. Different growth rates of pigmented and white hair in the beard: differentiation vs. proliferation? Br J Dermatol 1995; 132: 94–97
van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron 2004; 35: 193–200
van Neste D. Thickness, medullation and growth rate of female scalp hair are subject to significant variation according to pigmentation of scalp location during ageing. Eur J Dermatol 2004; 14: 28–32
Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975; 68: 1359–1365
Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001; 27: 53–54
Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin 1996; 14: 697–711
Sawaya ME, Price VH. Different levels of 5 alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109: 296–300
Venning VA, Dawber RPR. Patterned alopecia in women. J Am Acad Dermatol 1988: 18: 1073–1077
Price V, Sawaya M, Headington J, Kibarian M. Histology and hormonal activity in senescent thinning in males (abstract 266). J Invest Dermatol 2001; 117: 434
Griffiths CEM. The role of retinoids in the prevention and repair of aged and photoaged skin. Clin Exp Dermatol 2001; 26: 613–618
Nürnberg W, Beutler R, Drewes S, Schmidt K. Einfluss von Vitalstoffen auf den Alterungsprozess der Haut. Interventionsstudie zur Korrelation von Parametern der Hautalterung mit dem Mikronährstoff-Status. Ernährung & Medizin 2002; 17: 66–73
Piérard-Franchimont C, Uhoda I, Saint-Léger D, Piérard GE. Androgenetic alopecia and stress-induced premature senescence by cumulative ultraviolet light ex-posure. Exog Dermatol 2002; 1: 203–206
Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology 2003; 207: 343–348
Camacho F, Moreno JC, Garcia-Hernández. Telogen alopecia from UV rays. Arch Dermatol 1996; 132: 1398–1399
Johnsson A, Kjeldstad B, Melo TB. Fluorescence from pilosebaceous follicles. Arch Dermatol Res 1987; 279: 190–193
Pande CM, Albrecht L, Yang B. Hair photoprotection by dyes. J Cosmet Sci 2001; 52: 377–389
Gao T, Bedell A. Ultraviolet damage on natural gray hair and ist photoprotection. J Cosmet Sci 2001; 52: 103–118
Wissing SA, Muller RH. Solid lipid nanopartides (SLN) — a novel carrier for UV blockers. Pharmazie 2001; 56: 783–786
Bangha E, Eisner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acety1-5-methoxytryptamine). Arch Dermatol Res 1996; 288: 522–526
Sauermann G, Mei WP, Hoppe U, Stäb F. Ultraweak photon emission of human skin in vivo: influence of topically applied antioxidants on human skin. Methods Enzymol 1999; 300: 419–428
Chein E. Age Reversal, From Hormones to Telomeres. WorldLink Medical Publishing 1998
Kaufman KD. Clinical studies on the effects of oral finasteride, a type II 5 alpha-reductase inhibitor, on scalp hair in men with male pattern baldness. In: van Neste D, Randall VA (Hrsg.) Hair research for the next millenium. Elsevier, Amsterdam: 363–365, 1996
Kaufman KD, Olsen EA, Whiting DA, et al. Finasteride in the treatment of androgenetic alopecia. J Am Acad Dermatol 1998; 39: 578–589
Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999; 40: 930–937
The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multi-nation experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol 2003; 12: 38–49
Whiting DA, Olsen EA, Savin R et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur J Dermatol 2003; 13: 150–160
De Villez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol 1994; 3: 303–307
Olsen EA, Weiner MS, Delong ER et al. Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 1985; 13: 185–192
Olsen EA, DeLong ER, Weiner MS. Long-term follow-up of men with male pat-tern baldness treated with topical minoxidil. J Am Acad Dermatol 1987; 16: 688–695
Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol 1990; 22; 643–646
Olsen EA, Dunlap FE, Funicella T et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2002; 47: 377–385
Price VH, Menefee E. Quantitative estimation of hair growth I. Androgenetic alopecia in women: effect of minoxidil. J Invest Dermatol 1990; 95: 683–687
Lucky AW, Piacquadio DJ, Ditre CM et al. A randomized, placebo-controlled tri-al of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50: 541–553
Trüeb RM. Haarwaschmittel (Shampoos): Zusammensetzung und klinische Anwendungen. Hautarzt 1998; 49: 895–901
Mann T. Der Tod in Venedig und andere Erzählungen. Fischer, Hamburg 1977: S. 63
Trüeb RM. Haare. Praxis der Trichologie. Steinkopff Darmstadt 2003
Zit. nach Trüeb RM, Lier D. Hauptsache Haar. Das Haar im Spiegel von Medizin und Psychologie. Rüffer & Rub, Zurich 2002: S. 177
Rights and permissions
Copyright information
© 2006 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
(2006). Haut und Haare: Die dermatologische Perspektive. In: Anti-Aging. Steinkopff. https://doi.org/10.1007/978-3-7985-1637-3_17
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1637-3_17
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1636-6
Online ISBN: 978-3-7985-1637-3
eBook Packages: Medicine (German Language)